Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats

por Lesovaya, Ekaterina A., Kirsanov, Kirill I., Antoshina, Elena E., Trukhanova, Lubov S., Gorkova, Tatiana G., Shipaeva, Elena V., Salimov, Ramiz M., Belitsky, Gennady A., Blagosklonny, Mikhail V., Yakubovskaya, Marianna G., Chernova, Olga B.
Publicado 2015

Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo

por Fetisov, Timur I., Borunova, Anna A., Antipova, Alina S., Antoshina, Elena E., Trukhanova, Lubov S., Gorkova, Tatyana G., Zuevskaya, Svetlana N., Maslov, Alexei, Gurova, Katerina, Gudkov, Andrei, Lesovaya, Ekaterina A., Belitsky, Gennady A., Yakubovskaya, Marianna G., Kirsanov, Kirill I.
Publicado 2023

Physiological and Functional Effects of Dominant Active TCRα Expression in Transgenic Mice

por Kalinina, Anastasiia A., Ziganshin, Rustam Kh., Silaeva, Yulia Yu., Sharova, Nina I., Nikonova, Margarita F., Persiyantseva, Nadezda A., Gorkova, Tatiana G., Antoshina, Elena E., Trukhanova, Lubov S., Donetskova, Almira D., Komogorova, Victoria V., Litvina, Marina M., Mitin, Alexander N., Zamkova, Maria A., Bruter, Alexandra V., Khromykh, Ludmila M., Kazansky, Dmitry B.
Publicado 2023